UK markets closed

Foghorn Therapeutics Inc. (FHTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.07+0.51 (+9.17%)
As of 11:19AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
33,896
34,155
19,228
1,319
430
Operating expenses
Research development
105,238
109,689
105,618
80,325
57,715
Selling general and administrative
31,441
32,372
30,747
21,728
11,246
Total operating expenses
136,679
142,061
136,365
102,053
68,961
Operating income or loss
-102,783
-107,906
-117,137
-100,734
-68,531
Interest expense
-
-
0
1,906
979
Total other income/expenses net
2,850
2,831
2,580
1,261
-291
Income before tax
-89,288
-94,200
-108,882
-101,320
-68,800
Income tax expense
3,666
4,226
0
-
-
Income from continuing operations
-92,954
-98,426
-108,882
-101,320
-68,800
Net income
-92,954
-98,426
-108,882
-101,320
-68,800
Net income available to common shareholders
-92,954
-98,426
-108,882
-101,320
-68,800
Basic EPS
-2.46
-
-2.62
-2.73
-6.23
Diluted EPS
-2.46
-
-2.62
-2.73
-6.23
Basic average shares
41,867
-
41,591
37,171
11,047
Diluted average shares
41,867
-
41,591
37,171
11,047